[go: up one dir, main page]

AR054378A1 - Inhibidores de adenilatociclasa soluble, composiciones farmaceuticas que los contienen, y usos para controlar la fertilidad masculina - Google Patents

Inhibidores de adenilatociclasa soluble, composiciones farmaceuticas que los contienen, y usos para controlar la fertilidad masculina

Info

Publication number
AR054378A1
AR054378A1 ARP060102365A ARP060102365A AR054378A1 AR 054378 A1 AR054378 A1 AR 054378A1 AR P060102365 A ARP060102365 A AR P060102365A AR P060102365 A ARP060102365 A AR P060102365A AR 054378 A1 AR054378 A1 AR 054378A1
Authority
AR
Argentina
Prior art keywords
alkyl
acyl
aryl
alkoxy
cyano
Prior art date
Application number
ARP060102365A
Other languages
English (en)
Inventor
Bernd Buchmann
Duy Nguyen
Martin Fritsch
Bernd Menzenbach
Ulf Bomer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR054378A1 publication Critical patent/AR054378A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Reivindicacion 1: compuestos de la formula general (1) caracterizado porque R1 representa un H, halogeno, CF3, C3-6-cicloalquilo, que es opcionalmente polisaturado y opcionalmente polisustituido, o representa el grupo C1-6-alquilo, C1-6-arilo, C1-6- acilo, halo-C1-6-alquilo, C1-6-alquilo-C1-6-alquilo, C1-6-alquilo-C1-6-acilo, C1-6-acilo-C1-6-acilo, C1-6-alquilo-C1-6-arilo, C1-6-arilo-C1-6-alquilo o CF3; donde C1-6-alquilo, C1-6-arilo, C1-6-acilo, halo-C1-6-alquilo, C1-6-alquilo-C1-6-alquilo, C1- 6-alquilo-C1-6-acilo, C1-6-acilo-C1-6-acilo, C1-6-alquilo-C1-6-arilo o C1-6-arilo-C1-6-alquilo puede estar opcionalmente interrumpido de manera igual o diferentes con uno más O, S o N, o representa el grupo sulfonil-C1-6-alquilo, sulfonamida o ciano; R2 representa un halogeno, CF3, un C3-6-cicloalquilo, que es opcionalmente polisaturado y opcionalmente polisustituido, o representa el grupo C1-6-alquilo, C1-6-arilo, C1-6-acilo, halo-C1-6-alquilo, C1-6-alquilo-C1-6-alquilo, C1-6-alquilo-C1- 6-acilo, C1-6-acilo-C1-6-acilo, C1-6-alquilo-C1-6-arilo, C1-6-arilo-C1-6-alquilo o CF3; donde C1-6-alquilo, C1-6-arilo, C1-6-acilo, halo-C1-6-alquilo, C1-6-alquilo-C1-6-alquilo, C1-6-alquilo-C1-6-acilo, C1-6-acilo-C1-6-acilo, C1-6-alquilo-C1-6-arilo o C1-6-arilo-C1-6-alquilo puede estar opcionalmente interrumpido de manera igual o diferentes con uno más O, S o N, o representa el grupo sulfonil-C1-6-alquilo, sulfonamida o ciano; R3 representa C6-12-arilo, el que está sustituido opcionalmente con uno o más C1-6-alquilo o C1-6-acilo de manera igual o diferente, que puede estar mono- o polisustituido, o puede estar sustituido con C1-6-alcoxilo hidroxilo, ciano, CO2-(C1-6-alquilo), N-(C1-6-alquilo)2, CO-NR4R5 o con CF3, representa un C5-12- heteroarilo, que está sustituido de manera igual o diferente con uno o más halogeno, con C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo hidroxilo, ciano, CO2-(C1-6-alquilo), N-(C1-6-alquilo)2, CO-NR4R5 o con CF3 o representa un C3-6-cicloalquilo, que está sustituido con uno o más halogeno, CF3, hidroxilo, ciano, CO2-(C1-6-alquilo), C1-6-alquilo, C1-6-acilo, N-(C1-6-alquilo)2, CO-NR4R5 o C1-6-alcoxilo, de manera igual o diferente R4 representa un H, un C3-6-cicloalquilo, que está opcionalmente sustituido con uno o más C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo o CF3 de manera igual o diferente, representa un C6-12-arilo, que está opcionalmente sustituido con uno o más, halogeno, C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo N-C1-6-alquilo-C1-6- alquilo, CF3 o ciano de manera igual o diferente, o representa un C5-12-heteroarilo, que está opcionalmente sustituido con uno o más, halogeno, C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo N-C1-6-alquilo-C1-6-alquilo, CF3 o ciano, de manera igual o diferente, o es un C1-6-alquilo, que puede estar sustituido aleatoriamente, R5 es un H, un C3-6-cicloalquilo, que está opcionalmente sustituido con uno más, C1-6-alquilo, C1-6-acilo, 1-6-alcoxilo o CF3 de manera igual o diferente, o es un C6-12- arilo, que está opcionalmente sustituido de manera igual o diferente con uno o más halogeno o con un C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo N-C1-6-alquilo-C1-6-alquilo, CF3 o ciano, o es un C5-12-heteroarilo, que está opcionalmente sustituido con uno o más, halogeno, C1-6-alquilo, C1-6-acilo, C1-6-alcoxilo N-C1-6-alquilo-C1-6-alquilo, CF3 o ciano, de manera igual o diferente, o es un C1-6-alquilo, que puede estar sustituido aleatoriamente, R4 y R5 juntos pueden formar un anillo de 5-8 miembros que puede contener otros heteroátomos, y X es el grupo sulfonilo, (CH2)n o carbonilo; Y es un grupo -(CH2)2- o carbonilo; Z es un N; A es un O o S y n significa 0-4; así como sus isomeros, diastereomeros, enantiomeros y sales.
ARP060102365A 2005-06-08 2006-06-07 Inhibidores de adenilatociclasa soluble, composiciones farmaceuticas que los contienen, y usos para controlar la fertilidad masculina AR054378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
AR054378A1 true AR054378A1 (es) 2007-06-20

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102365A AR054378A1 (es) 2005-06-08 2006-06-07 Inhibidores de adenilatociclasa soluble, composiciones farmaceuticas que los contienen, y usos para controlar la fertilidad masculina

Country Status (23)

Country Link
EP (1) EP1888058B1 (es)
JP (1) JP2008542422A (es)
KR (1) KR20080016617A (es)
CN (1) CN101193631A (es)
AR (1) AR054378A1 (es)
AT (1) ATE431736T1 (es)
AU (1) AU2006256857A1 (es)
BR (1) BRPI0610934A2 (es)
CA (1) CA2606692A1 (es)
CR (1) CR9578A (es)
DE (2) DE102005027274A1 (es)
DO (1) DOP2006000130A (es)
EA (1) EA200702590A1 (es)
EC (1) ECSP078024A (es)
GT (1) GT200600244A (es)
IL (1) IL186914A0 (es)
MX (1) MX2007015493A (es)
NO (1) NO20080104L (es)
PE (1) PE20061488A1 (es)
TW (1) TW200716090A (es)
UY (1) UY29583A1 (es)
WO (1) WO2006131398A2 (es)
ZA (1) ZA200800153B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase
WO2023100061A1 (en) 2021-12-01 2023-06-08 Pfizer Inc. 3-phenyl-1-benzothiophene-2-carboxylic acid derivatives as branched-chain alpha keto acid dehydrogenase kinase inhibitors for the treatment of diabetes, kidney diseases, nash and heart failure

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
AU2001287060A1 (en) * 2000-09-05 2002-03-22 University Of Virginia Patent Foundation Human soluble testicular adenylyl cyclase
UA75660C2 (en) * 2001-06-28 2006-05-15 Pfizer Prod Inc Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
AU2002327627B2 (en) * 2001-09-14 2006-09-14 Methylgene Inc. Inhibitors of histone deacetylase
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
JP4741491B2 (ja) * 2003-08-07 2011-08-03 ライジェル ファーマシューティカルズ, インコーポレイテッド 抗増殖剤としての2,4−ピリミジンジアミン化合物および使用
US7935724B2 (en) * 2003-10-09 2011-05-03 Merck Hdac Research, Llc Thiophene and benzothiophene hydroxamic acid derivatives
CA2553848A1 (en) * 2004-01-21 2005-08-04 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
WO2005092899A1 (en) * 2004-03-26 2005-10-06 Methylgene Inc. Inhibitors of histone deacetylase
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
KR20080016617A (ko) 2008-02-21
EA200702590A1 (ru) 2008-06-30
ECSP078024A (es) 2008-01-23
AU2006256857A1 (en) 2006-12-14
ATE431736T1 (de) 2009-06-15
UY29583A1 (es) 2007-01-31
NO20080104L (no) 2008-03-03
EP1888058B1 (en) 2009-05-20
PE20061488A1 (es) 2007-02-03
DE602006006908D1 (de) 2009-07-02
IL186914A0 (en) 2008-02-09
EP1888058A2 (en) 2008-02-20
GT200600244A (es) 2007-01-23
CN101193631A (zh) 2008-06-04
DOP2006000130A (es) 2006-11-30
WO2006131398A2 (en) 2006-12-14
BRPI0610934A2 (pt) 2010-08-03
JP2008542422A (ja) 2008-11-27
CR9578A (es) 2008-03-06
WO2006131398A3 (en) 2007-04-19
DE102005027274A1 (de) 2006-12-14
TW200716090A (en) 2007-05-01
MX2007015493A (es) 2008-02-22
CA2606692A1 (en) 2006-12-14
ZA200800153B (en) 2009-03-25

Similar Documents

Publication Publication Date Title
AR061739A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ECSP066898A (es) Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento
AR053672A1 (es) Una composicion y metodo para hacer un entibador
AR058776A1 (es) Compuesto de piridina condensado
CO2018005848A2 (es) Compuestos de pirazol o sus sales, métodos de preparación de los mismos, composiciones herbicidas y su uso
AR091790A1 (es) Derivados de isoquinolin-1-ona y sus usos
ECSP099781A (es) Novedosos compuestos que son inhibidores de erk
AR061642A1 (es) Derivados de ureas de tropano, su preparacion y su aplicacion en terapeu-tica, procesos de obtencion y composiciones farmaceuticas
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
AR067646A1 (es) Ariloxazoles sustituidos y su uso
UY29176A1 (es) Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen, métodos para su preparación y sus usos.
CO6270226A2 (es) Nuevos compuestos espirociclicos como antagonistas de cgrp
UY28040A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos.
AR048086A1 (es) Bencenodicarboxamidas insecticidas
CO6361956A2 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmaceúticas que los contienen
AR072962A1 (es) Derivados de pirimidin-4-ona sustituidos
AR074053A1 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y composiciones farmaceuticas que los contienen
AR049883A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion, y su empleo como medicamentos
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
AR070187A1 (es) Derivados de dulfonamidas sustituidas
AR060810A1 (es) Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn
ECSP066536A (es) Derivados de acidos fenoxiaceticos utiles como agonistas dobles dereceptor activado por proliferador de peroxisoma
UY30502A1 (es) " azolilmetiloxiranos, su uso para combatir hongos fitopatógenos, así como productos que los contienen (vi) "
AR077366A1 (es) 2-carboxamida cicloaminoureas sustituidas inhibidoras de quinasas de fosfatidil inositol-3(pi3ks), composiciones farmaceuticas que las contienen y usos de las mismas en el tratamiento de enfermedades proliferativas.
UY28765A1 (es) Compuestos de piperazina acetilínica y su uso como antagonistas del receptor de glutamato metabotrópico

Legal Events

Date Code Title Description
FB Suspension of granting procedure